Cargando…
RAD52: Paradigm of Synthetic Lethality and New Developments
DNA double-strand breaks and inter-strand cross-links are the most harmful types of DNA damage that cause genomic instability that lead to cancer development. The highest fidelity pathway for repairing damaged double-stranded DNA is termed Homologous recombination (HR). Rad52 is one of the key HR pr...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650160/ https://www.ncbi.nlm.nih.gov/pubmed/34887904 http://dx.doi.org/10.3389/fgene.2021.780293 |
_version_ | 1784611148027396096 |
---|---|
author | Rossi, Matthew J. DiDomenico, Sarah F. Patel, Mikir Mazin, Alexander V. |
author_facet | Rossi, Matthew J. DiDomenico, Sarah F. Patel, Mikir Mazin, Alexander V. |
author_sort | Rossi, Matthew J. |
collection | PubMed |
description | DNA double-strand breaks and inter-strand cross-links are the most harmful types of DNA damage that cause genomic instability that lead to cancer development. The highest fidelity pathway for repairing damaged double-stranded DNA is termed Homologous recombination (HR). Rad52 is one of the key HR proteins in eukaryotes. Although it is critical for most DNA repair and recombination events in yeast, knockouts of mammalian RAD52 lack any discernable phenotypes. As a consequence, mammalian RAD52 has been long overlooked. That is changing now, as recent work has shown RAD52 to be critical for backup DNA repair pathways in HR-deficient cancer cells. Novel findings have shed light on RAD52’s biochemical activities. RAD52 promotes DNA pairing (D-loop formation), single-strand DNA and DNA:RNA annealing, and inverse strand exchange. These activities contribute to its multiple roles in DNA damage repair including HR, single-strand annealing, break-induced replication, and RNA-mediated repair of DNA. The contributions of RAD52 that are essential to the viability of HR-deficient cancer cells are currently under investigation. These new findings make RAD52 an attractive target for the development of anti-cancer therapies against BRCA-deficient cancers. |
format | Online Article Text |
id | pubmed-8650160 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86501602021-12-08 RAD52: Paradigm of Synthetic Lethality and New Developments Rossi, Matthew J. DiDomenico, Sarah F. Patel, Mikir Mazin, Alexander V. Front Genet Genetics DNA double-strand breaks and inter-strand cross-links are the most harmful types of DNA damage that cause genomic instability that lead to cancer development. The highest fidelity pathway for repairing damaged double-stranded DNA is termed Homologous recombination (HR). Rad52 is one of the key HR proteins in eukaryotes. Although it is critical for most DNA repair and recombination events in yeast, knockouts of mammalian RAD52 lack any discernable phenotypes. As a consequence, mammalian RAD52 has been long overlooked. That is changing now, as recent work has shown RAD52 to be critical for backup DNA repair pathways in HR-deficient cancer cells. Novel findings have shed light on RAD52’s biochemical activities. RAD52 promotes DNA pairing (D-loop formation), single-strand DNA and DNA:RNA annealing, and inverse strand exchange. These activities contribute to its multiple roles in DNA damage repair including HR, single-strand annealing, break-induced replication, and RNA-mediated repair of DNA. The contributions of RAD52 that are essential to the viability of HR-deficient cancer cells are currently under investigation. These new findings make RAD52 an attractive target for the development of anti-cancer therapies against BRCA-deficient cancers. Frontiers Media S.A. 2021-11-23 /pmc/articles/PMC8650160/ /pubmed/34887904 http://dx.doi.org/10.3389/fgene.2021.780293 Text en Copyright © 2021 Rossi, DiDomenico, Patel and Mazin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Rossi, Matthew J. DiDomenico, Sarah F. Patel, Mikir Mazin, Alexander V. RAD52: Paradigm of Synthetic Lethality and New Developments |
title | RAD52: Paradigm of Synthetic Lethality and New Developments |
title_full | RAD52: Paradigm of Synthetic Lethality and New Developments |
title_fullStr | RAD52: Paradigm of Synthetic Lethality and New Developments |
title_full_unstemmed | RAD52: Paradigm of Synthetic Lethality and New Developments |
title_short | RAD52: Paradigm of Synthetic Lethality and New Developments |
title_sort | rad52: paradigm of synthetic lethality and new developments |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650160/ https://www.ncbi.nlm.nih.gov/pubmed/34887904 http://dx.doi.org/10.3389/fgene.2021.780293 |
work_keys_str_mv | AT rossimatthewj rad52paradigmofsyntheticlethalityandnewdevelopments AT didomenicosarahf rad52paradigmofsyntheticlethalityandnewdevelopments AT patelmikir rad52paradigmofsyntheticlethalityandnewdevelopments AT mazinalexanderv rad52paradigmofsyntheticlethalityandnewdevelopments |